ABL Bio (XKRX:298380) Marketable Securities : ₩39,365 Mil (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is ABL Bio Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. ABL Bio's Marketable Securities for the quarter that ended in Mar. 2024 was ₩39,365 Mil.

ABL Bio's annual Marketable Securities increased from Dec. 2021 (₩22,132 Mil) to Dec. 2022 (₩53,181 Mil) but then declined from Dec. 2022 (₩53,181 Mil) to Dec. 2023 (₩43,101 Mil).

ABL Bio Marketable Securities Historical Data

The historical data trend for ABL Bio's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ABL Bio Marketable Securities Chart

ABL Bio Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Marketable Securities

Get a 7-Day Free Trial

42,141.49

29,732.65

22,132.34

53,181.36

43,101.13

ABL Bio Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Marketable Securities	Get a 7-Day Free Trial															69,407.26	74,721.32	65,535.19	43,101.13	39,364.75

ABL Bio Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

ABL Bio (XKRX:298380) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

ABL Bio Marketable Securities Related Terms

Thank you for viewing the detailed overview of ABL Bio's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

ABL Bio (XKRX:298380) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ABL Bio Inc (XKRX:298380) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

N/A

Address

2nd Floor, 16 Daewangpangyo-Ro 712, Beon-Gil, Bundang-Gu, Gyeonggi-do, Seongnam-si, KOR, 13488

Website

https://www.ablbio.com

ABL Bio Inc is a Korean biotech research company. The company is engaged in the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases. Its pipeline products include ABL001 an Bispecific Antibody, ABL201-205 an Antibody Drug Conjugate, T cell engager, Dual Immune Cell Targeting BsAb an Immuno-Oncology, ABL301 an BBB-Penetrating Bispecific Antibody.

ABL Bio (XKRX:298380) Headlines

No Headlines